Milestone Pharmaceuticals, Inc. (MIST)
1.42
-0.02
(-1.39%)
USD |
NASDAQ |
May 29, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Milestone Pharmaceuticals Shareholders Equity (Quarterly) : 36.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 3.971M |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | 8.238M |
| Pharmagreen Biotech, Inc. | -9.351M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 193.73M |
| Total Liabilities (Quarterly) | 157.68M |
| Debt to Equity Ratio | 3.810 |
| Current Ratio | 9.179 |
| Net Debt Paydown Yield | -11.78% |